Triomics is a generative AI-powered platform that matches patients to clinical trials.
Triomics's investors include General Catalyst, Lightspeed Venture Partners, Nexus Venture Partners, Y Combinator, Battery Ventures.
Triomics is headquartered in San Francisco, United States.
Triomics is a generative AI-powered platform that matches patients to clinical trials.
Triomics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Triomics — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/triomics. Accessed July 19, 2026.
VCBacked. (2026). Triomics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/triomics
{{cite web |title=Triomics — Funding & Investors |url=https://www.vcbacked.co/company/triomics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated